Back to top
more

Phibro Animal Health (PAHC)

(Real Time Quote from BATS)

$25.00 USD

25.00
108,616

+1.15 (4.82%)

Updated Nov 11, 2024 11:56 AM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

1-Strong Buy of 5 1        

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value B Growth B Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 30% (74 out of 250)

Industry: Medical - Products

Zacks News

Here's Why You Should Retain ABT Stock in Your Portfolio Now

Investors feel optimistic about Abbott's robust strength in the Diagnostics and Nutrition business. Yet, unfavorable forex impacts are concerning.

Is GMED Stock a Smart Addition to Your Portfolio Right Now?

Globus Medical's synergistic merger with NuVasive and a cadence of product launches bring optimism to investors.

Is biote Corp. (BTMD) a Great Value Stock Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

ICLR Misses on Q3 Earnings, Lowers 2024 Guidance, Stock Falls

ICON's third-quarter 2024 earnings lag estimates due to its large customers undergoing significant development model shifts with resulting cost pressures and the biotech market's slower recovery.

EW Q3 Earnings Match Estimates, Revenues Miss, Stock Falls

Edwards Lifesciences reports strong contributions from all of the product groups - TAVR, TTMT and surgical structural heart - in the third quarter of 2024.

LH Beats on Q3 Earnings, Raises Revenue Guidance Midpoint, Stock Gains

Labcorp beats on earnings and revenues in the third quarter, entering the fourth half of 2024 with robust momentum.

Why Phibro Animal Health (PAHC) is a Top Value Stock for the Long-Term

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Is Insulet Stock a Smart Addition to Your Portfolio Right Now?

PODD continues to make strides with Omnipod 5 and its market expansion. Robust solvency is a plus.

Benjamin Rains headshot

Finding Great Top-Ranked Momentum Stocks to Buy Now

The stocks we learn to search for today are top-ranked momentum stocks that might be worth buying to close out October and throughout the last two months of 2024.

PAHC vs. PODD: Which Stock Is the Better Value Option?

PAHC vs. PODD: Which Stock Is the Better Value Option?

DGX Stock Rises on Q3 Earnings and Revenue Beat, 2024 Sales View Up

Quest Diagnostics' third-quarter 2024 performance reflects impressive DIS business growth and the benefits of new acquisitions.

Brainsway Ltd. Sponsored ADR (BWAY) Hits Fresh High: Is There Still Room to Run?

Brainsway (BWAY) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Is ResMed Stock a Smart Addition to Your Portfolio Right Now?

RMD's robust mask business and efforts to boost its SaaS business are encouraging.

Zacks.com featured highlights include Nordstrom, Phibro Animal Health, AllianceBernstein, Carnival and Jackson Financial

Nordstrom, Phibro Animal Health, AllianceBernstein, Carnival and Jackson Financial are part of the Zacks Screen of the Week article.

Nilanjan Choudhury headshot

Grab These 5 Relative Price Strength Stocks for Strong Returns

JWN, PAHC, AB, CCL and JXN are five stocks with explosive relative price strength.

WBA Stock Up on Q4 Earnings & Revenues Beat, Unveils Strategic Action

Walgreens reports better-than-expected earnings and revenues in the fourth quarter of fiscal 2024.

Is Phibro Animal Health (PAHC) Stock Undervalued Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Best Momentum Stock to Buy for October 10th

TCEHY, EFX and PAHC made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on October 10, 2024.

Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

New Strong Buy Stocks for October 10th

NEXN, CVNA, PAHC, SOHO and HENKY have been added to the Zacks Rank #1 (Strong Buy) List on October 10, 2024.

Here's Why You Should Retain Penumbra Stock in Your Portfolio Now

Investors feel optimistic about PEN's strong growth prospects in the Thrombectomy business. Yet, unfavorable forex impacts are concerning.

Should You Add Quest Diagnostics Stock to Your Portfolio Right Now?

DGX's strength in Advanced Diagnostics and robust base business volumes are encouraging.

Reasons to Retain Chemed Stock in Your Portfolio Now

Investors feel optimistic about CHE's strong growth prospects in the VITAS business. Yet, unfavorable macroeconomic conditions are concerning.

TMO's New ICP-MS Systems Boost Trace Element Analysis: Stock to Gain?

Thermo Fisher introduces the iCAP MX Series ICP-MS to simplify trace elemental analysis.

Reasons to Retain QIAGEN Stock in Your Portfolio for Now

Investors feel optimistic about QGEN's strong growth prospects in the NGS platforms. Yet, an unfavorable currency impact on the company's operations is cornering.